The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The short-term outcomes from TOP-G trial: Ramdomized phase II noninferiority trial comparing gastrectomy with omentectomy and omentum preserving gastrectomy for advanced gastric cancer.
 
Takanobu Yamada
No Relationships to Disclose
 
Hitoshi Murakami
No Relationships to Disclose
 
Masataka Taguri
No Relationships to Disclose
 
Shinichi Hasegawa
No Relationships to Disclose
 
Takeharu Yamanaka
Employment - Merck (I); Merck (I); Merck (I); Merck (I)
Honoraria - Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Takeda; Takeda; Takeda; Takeda
Consulting or Advisory Role - Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; HUYA Bioscience International; HUYA Bioscience International; HUYA Bioscience International; HUYA Bioscience International; Sysmex; Sysmex; Sysmex; Sysmex
Research Funding - Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Chugai/Roche (Inst); Chugai/Roche (Inst); Chugai/Roche (Inst); Chugai/Roche (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst)
 
Yasushi Rino
No Relationships to Disclose
 
Hiroyuki Mushiake
No Relationships to Disclose
 
Takashi Oshima
No Relationships to Disclose
 
Hiroshi Matsukawa
No Relationships to Disclose
 
Kazuyuki Tani
No Relationships to Disclose
 
Yoshihiro Suzuki
No Relationships to Disclose
 
Yukihiro Ozawa
No Relationships to Disclose
 
Hiroyasu Tanabe
No Relationships to Disclose
 
Tsutomu Sato
No Relationships to Disclose
 
Hiroshi Tamagawa
No Relationships to Disclose
 
Norio Yukawa
No Relationships to Disclose
 
Takaki Yoshikawa
Honoraria - Abbott Nutrition; Abbott Nutrition; Abbott Nutrition; Abbott Nutrition; Ajinomoto; Ajinomoto; Ajinomoto; Ajinomoto; Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Lilly; Lilly; Lilly; Lilly; Medtronic; Medtronic; Medtronic; Medtronic; Miyarisan pharmaceutical; Miyarisan pharmaceutical; Miyarisan pharmaceutical; Miyarisan pharmaceutical; Miyarisan pharmaceutical; Miyarisan pharmaceutical; Miyarisan pharmaceutical; Miyarisan pharmaceutical; MSD; MSD; MSD; MSD; Nihonkayaku; Nihonkayaku; Nihonkayaku; Nihonkayaku; Olympus; Olympus; Olympus; Olympus; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; TERUMO; TERUMO; TERUMO; TERUMO; TERUMO; TERUMO; TERUMO; TERUMO
Consulting or Advisory Role - Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Novartis; Novartis; Novartis; Novartis
Research Funding - Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma; Lilly; Lilly; Lilly; Lilly; Lilly; Lilly; Lilly; Lilly; Lilly; Lilly; Lilly; Lilly; Novartis; Novartis; Novartis; Novartis; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Yakult Pharmaceutical; Yakult Pharmaceutical; Yakult Pharmaceutical; Yakult Pharmaceutical
 
Toshio Imada
No Relationships to Disclose
 
Munetaka Masuda
No Relationships to Disclose
 
Yuji Yamamoto
No Relationships to Disclose